Skip to main content
. 2023 Jun 5;330(1):43–51. doi: 10.1001/jama.2023.9526

Figure 3. Distribution of Genes for Patients With Pathogenic Results.

Figure 3.

The results are grouped by associated cancer types or hereditary syndromes and by practice guideline indications for testing across selected cancer types (additional details appear in eTable 1 in Supplement 1).